Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. - Wikidata - awgldk - TriplyDB

Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.

Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.

http://www.wikidata.org/entity/Q34414680

about

Vilanterol and fluticasone for asthma Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].The use of inhaled corticosteroids in pediatric asthma: update Cell cycle phase regulates glucocorticoid receptor function Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy Potential mechanisms to explain how LABAs and PDE4 inhibitors enhance the clinical efficacy of glucocorticoids in inflammatory lung diseases Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases Inhaled Corticosteroids Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.Immunological Features of Chronic Obstructive Pulmonary Disease (COPD) Induced by Indoor Pollution and Cigarette Smoke Small airways dysfunction in asthma: evaluation and management to improve asthma control.Vilanterol and fluticasone furoate for asthma.Glucocorticosteroids: current and future directions.Comparison of the efficacy of ciclesonide with that of budesonide in mild to moderate asthma patients after step-down therapy: a randomised parallel-group study.Biochemical basis of asthma therapy.p38 mitogen-activated protein kinase-γ inhibition by long-acting β2 adrenergic agonists reversed steroid insensitivity in severe asthma Synergistic effect of formoterol and mometasone in a mouse model of allergic lung inflammation.Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes.Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease.Update in asthma 2005.A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids.Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition Modulatory role for retinoid-related orphan receptor alpha in allergen-induced lung inflammation.Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease.Pharmacogenetics and the development of personalized approaches for combination therapy in asthma.Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease.Salmeterol/fluticasone propionate combination in the treatment of COPD.Budesonide/formoterol in the treatment of asthma.Corticosteroid resistance and novel anti-inflammatory therapies in chronic obstructive pulmonary disease: current evidence and future direction.Treating the small airways.Evaluation of salmeterol xinafoate plus fluticasone propionate for the treatment of chronic obstructive pulmonary disease.Inhaled corticosteroids for asthma: on-demand or continuous use.Enhancing nuclear translocation: perspectives in inhaled corticosteroid therapy.Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.Comparing clinical efficacy of Symbicort versus Pulmicort in reducing asthma symptom and improving its control.

P2860

Q24197900-50D31EB1-C004-4899-A7CF-50F4039D9878 Q25257397-62580170-87BF-437A-9918-6767E46A3AEC Q26739763-F359AB06-1011-4CC6-AC25-C7CCF7F5133E Q27331735-E1431277-36E5-447B-9452-BAA90F7B772F Q28077040-8D5B2F0C-D467-4988-B5DE-1CF8ADCCBAF2 Q28083987-12760129-E9BE-44DF-A95B-DF3996D08FD5 Q28391808-6F98F46A-F80C-47AE-998A-C7FD8AE86AA7 Q28475451-E54A8143-F9CF-472C-AF0A-A53177C32EEF Q33636430-F5FB0272-844D-4709-94DD-7D966216FDC1 Q33664193-8CA5D6CF-960E-4F5C-8D2E-F9C6965E9B6A Q33803143-F2FDC9A9-59AE-417C-9C24-ED38E6B092D6 Q34126693-6C86A1E7-20A5-43AC-A9F0-BDCE3FB4892F Q34167882-65404508-F593-4537-8224-20E07B207648 Q34539126-FA2581F1-6B6E-4148-A1F9-A8F66395C749 Q34903070-EE4F6491-2D74-499F-8989-48CB7101B638 Q35216003-6E4D3849-3D97-4B70-8CD4-08BEE62D088F Q35312155-1FECCB15-C451-43E6-A2E8-5FAB6BFC848F Q35586057-28665B0E-CE0A-40A3-A22A-2373E0F562A4 Q35995243-094A175C-99B9-4E5D-87DD-4F771055B7BB Q36160624-66FC17F4-E452-4A6C-9739-F0777A4877BC Q36227904-26B5FABE-B8D2-4F97-B3F1-24F775292FDE Q36238026-B891C2AC-FB97-49BD-9D53-087459CFB9D9 Q36301783-4739A444-DE19-4257-98E8-E0439A29B8A3 Q36429918-371A514E-91CD-4F23-AB96-BDBE8174EF83 Q36510045-57B42B33-19CB-4F2E-8521-B4AD9098862A Q36619748-2FBC9766-2681-423D-BA66-B2F4F3F05877 Q37110756-D6109A8D-B355-4FA1-A8D7-4977A97733C7 Q37153293-18704D57-267C-4B08-B2DA-9CF9D5E0D807 Q37425660-3B4B7E00-77C8-4280-A03D-0FAA73B44C39 Q37729825-9431056B-4166-4626-9B16-8C1A2545EDD4 Q37748948-4498FCF3-6C21-4241-9892-4F8B7246F11A Q37754942-48CC1887-9F27-47FC-9030-4DF219B33614 Q37798026-CE3852DE-C289-45DF-9015-ECABA48734E2 Q38021518-33A09E76-B4BC-41F0-83AA-DBBBFEC57404 Q38060087-CAB10EFF-0203-490B-A314-3B60599CB84A Q38125210-702B970B-9035-4F71-9B69-887F633DE70D Q38154624-0B870409-CCD6-4E27-8236-AE3FBBDFC6D5 Q38495012-8E0B50EA-F441-44F9-9B43-19252ADDD436 Q38707759-B750C614-8668-4BAB-A003-5A6C6EB6D420 Q38782680-D5EE8D00-61B9-48D7-A974-7F60295E38A9

P2860

Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.

http://www.wikidata.org/entity/Q34414680

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Glucocorticoid receptor nuclea ...... r inhaled combination therapy.

@ast

Glucocorticoid receptor nuclea ...... r inhaled combination therapy.

@en

Glucocorticoid receptor nuclea ...... r inhaled combination therapy.

@nl

type

label

Glucocorticoid receptor nuclea ...... r inhaled combination therapy.

@ast

Glucocorticoid receptor nuclea ...... r inhaled combination therapy.

@en

Glucocorticoid receptor nuclea ...... r inhaled combination therapy.

@nl

prefLabel

Glucocorticoid receptor nuclea ...... r inhaled combination therapy.

@ast

Glucocorticoid receptor nuclea ...... r inhaled combination therapy.

@en

Glucocorticoid receptor nuclea ...... r inhaled combination therapy.

@nl

P1433

Q34414680-EF3ABFD8-89D1-43CF-A76B-499F628CF1D2

P1476

Q34414680-E9D9CDDB-EAF0-4CA6-AEBF-BF051D16D18D

P2093

Q34414680-0DF3EFB7-B549-4EA5-B10C-EFA57EFE34DF

Q34414680-2D06D6F6-7C26-427F-8E1D-1FB8CE28C9C1

Q34414680-601A969C-C9B3-4330-880F-B1B57D8D0F1A

Q34414680-6F0C67F5-6B37-43DB-947C-D5C1E36F7C3C

Q34414680-84A03EA4-3BF9-4357-8609-7CF65A1224FE

Q34414680-E0FCE46C-CB1D-4837-8CEF-86995AFE15B6

P2860

Q34414680-05DF6A45-DA81-458E-BE38-2530A3D1205E

Q34414680-0B19B266-05B2-43BB-89E0-1399272AD1B8

Q34414680-184A3AA7-BCF5-40FC-B088-01FA5B240745

Q34414680-20BCA8E2-8F6C-4E3D-AC9B-BA1291969081

Q34414680-23FBAC9F-D568-439A-B1DC-D0D79833C3B9

Q34414680-2930C1EA-04FB-46D7-86D2-5CDE403B1903

Q34414680-29762EA7-E11A-4BC0-8406-6AC23F5BBC12

Q34414680-47E4F86E-1D62-431B-9F93-71B88B2639DC

Q34414680-49A08310-E5B6-4C21-B29C-F446FA4EAD40

Q34414680-551F1A90-B55C-41D8-B633-A6472787BF4C

P304

Q34414680-59D54647-5426-4A13-8408-20AC8B33052F

P31

Q34414680-F9C1DC5E-94DB-4A9A-B3D4-0CD8EB8938E9

P356

Q34414680-AB5535A8-48BF-4541-821D-8D5E7889B263

P407

Q34414680-516C1845-1B39-4E8A-AD01-DEED593C1FD7

P433

Q34414680-DF118729-CEC5-4D68-B917-DE129A6AC4A3

P478

Q34414680-26034C72-ABA1-4075-B72A-788744DDABF0

P50

Q34414680-F4F0A171-A305-44A9-B57E-09444AB82A74

P577

Q34414680-8C236A1D-4773-4630-9937-75CE73557150

P5875

Q34414680-6C05E636-EE58-40A5-8D52-F06A5C315E63

P698

Q34414680-E38C78B1-E999-491D-BDD2-A173DDEA5F48

P356

RCCM.200408-1041OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Glucocorticoid receptor nuclea ...... er inhaled combination therapy

@en

P2093

Kazuhiro Ito

http://www.w3.org/2001/XMLSchema#string

Kittipong Maneechotesuwan

http://www.w3.org/2001/XMLSchema#string

Malcolm Johnson

http://www.w3.org/2001/XMLSchema#string

Misako Ito

http://www.w3.org/2001/XMLSchema#string

Omar S Usmani

http://www.w3.org/2001/XMLSchema#string

Peter J Barnes

http://www.w3.org/2001/XMLSchema#string

P2860

Serine/threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma

Steroid hormone receptors: many actors in search of a plot

Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines

Cytokines in asthma.

Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12.

Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids.

Molecular interactions between glucocorticoids and long-acting beta2-agonists.

P304

704-712

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200408-1041OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7877012

http://www.w3.org/2001/XMLSchema#string

P698

15860753

http://www.w3.org/2001/XMLSchema#string